Search

Search Constraints

You searched for: Author/Creator Chaput, Nathalie

Search Results

1. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. Issue 1 (31st December 2015)

3. CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers. Issue 2 (7th February 2022)

4. Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. (March 2023)

5. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis. (December 2022)

7. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. (2nd April 2016)

9. Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors. (January 2019)

10. Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial. (April 2022)